Stockscreener 앱 받기
0.86%
Pfizer Inc 주식(PFE)의 최신 뉴스
When You Look Back in a Few Years, You'll Wish You Had Bought This Unstoppable Artificial Intelligence (AI) Stock - The Motley Fool
Pfizer CEO expected at Trump fundraiser - breakingthenews.net
Pfizer CEO attending $25 million fundraiser at Trump's golf club after president demands drug price cuts, sources say - CBS News
Scooplet: The CEO of @Pfizer, Albert Bourla, is among those expected at the fundraiser President Trump is attending tonight, sources told @CBSNews. Trump yday sent letters to pharmaceutical companies, including Pfizer, demanding they lower U.S. drug pri - twitter.com
Pfizer’s Abrysvo Study: A Closer Look at Safety in Pregnant Women and Infants - TipRanks
Pfizer’s Ngenla Study: A Closer Look at Long-Term Safety for GHD Treatment - TipRanks
Pfizer’s TALZENNA Study: A New Hope for Prostate Cancer Treatment? - TipRanks
Pfizer’s Latest Clinical Study Update: Avelumab and Axitinib in Renal Cell Cancer - TipRanks
Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win - Reuters
Pfizer’s New Study on PF-07934040: A Potential Game-Changer in Cancer Treatment? - TipRanks
Pfizer’s New Study on Abrocitinib: A Potential Breakthrough for Pediatric Eczema - TipRanks
Pfizer’s Ongoing Safety Study of BNT162b2 in Korea: Key Insights for Investors - TipRanks
Pfizer’s Phase 3 Study: Evaluating Co-administration of RSV and Shingles Vaccines - TipRanks
Moderna Fights Off Pfizer Challenge To Surviving mRNA IP - Law360
Moderna Wins UK Patent Battle Against Pfizer and BioNTech - BioSpace
Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q2 Earnings - Nasdaq
Pfizer/BioNTech lose appeal to reverse Moderna’s COVID vaccine patent win in U.K. - Seeking Alpha
How To Trade Pfizer Stock Ahead of Its Upcoming Earnings? - Trefis
Should You Buy Pfizer (PFE) Stock Before August 5? Here's What History Says - MSN
Pfizer losses appeal in Moderna patent case - breakingthenews.net
UK Court of Appeal Confirms Moderna’s EP'949 Patent is Valid and Infringed by Pfizer/BioNTech - The Daily Reflector
Moderna Secures Major Patent Victory: UK Court Rules Pfizer Infringed COVID-19 Vaccine Technology - Stock Titan
Pfizer (PFE) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Trump Demands Pharma Companies Slash US Drug Prices in Letter - Bloomberg
Trump demands largest pharma companies slash US drug prices - Yahoo Finance
Purdue and Gleaners Food Bank to Open Pharmacy, Concerns Over Eli Lilly and Pfizer Relationship, IU Researchers get Top Awards, Ground Breaking for New Subsidized Housing - WFYI
Pfizer’s Promising Phase 2 Study on Advanced Breast Cancer Treatment - TipRanks
Pfizer’s Promising Phase 3 Study on NSCLC Treatment: A Market Game-Changer? - TipRanks
Pfizer’s New Hope: PF-08046031 Study in Advanced Melanoma and Solid Tumors - TipRanks
Pfizer’s MagnetisMM-32 Study: A New Hope for Multiple Myeloma Treatment - TipRanks
Pfizer’s Latest Study on HER2-positive Breast Cancer: A Real-World Perspective - TipRanks
Pfizer’s COVID-19 Vaccine Study: Key Insights and Market Impact - TipRanks
Pfizer and Astellas Advance Prostate Cancer Study with Promising Drug Combo - TipRanks
Pfizer’s Phase 3 Study on Elranatamab vs. Lenalidomide: A Potential Game-Changer in Multiple Myeloma Treatment - TipRanks
Pfizer and Genmab’s Tivdak Study: Assessing Ocular Safety in Cervical Cancer Treatment - TipRanks
Pfizer’s TALZENNA Study: A Potential Game-Changer in Breast Cancer Treatment - TipRanks
Pfizer’s Sisunatovir Study: A Promising Step in RSV Treatment - TipRanks
Pfizer’s Elranatamab Study: A Real-World Insight into Multiple Myeloma Treatment - TipRanks
Stay Ahead of the Game With Pfizer (PFE) Q2 Earnings: Wall Street's Insights on Key Metrics - Yahoo Finance
Pfizer: Lack Of Enthusiasm Shouldn't Surprise You - Seeking Alpha
Where Will Pfizer (PFE) Be in 5 Years? - AOL.com
Bank of America Securities Maintains a Hold on Pfizer (PFE) - Insider Monkey
Pfizer Shares Plunge 2.02% Amid Vaccine Advances and Cancer Deal, Ranked 118th in $860M Trading Volume - AInvest
Pfizer’s (PFE) Breakthrough Medicines Power its Dividend Stability - Insider Monkey
Pfizer’s Gene Therapy Study for Duchenne Muscular Dystrophy: A Market Game-Changer? - TipRanks
Pfizer’s Phase 3 Study on Avelumab and Axitinib in Renal Cancer: A Market Game-Changer? - TipRanks
Pfizer’s New Study on Abrocitinib: A Potential Game-Changer for Pediatric Eczema - TipRanks
Pfizer’s Latest Clinical Study: A Potential Game-Changer in Cancer Treatment - TipRanks
Middle East and Asia Pacific Biotechnology Market Is Booming So - openPR.com
Buy, Sell Or Hold Pfizer Stock? Key Tips Ahead Of Q2 Earnings - Barchart.com
Time to Go Short on Pfizer (PFE)? - Insider Monkey
Pfizer plans to continue work in Russia in years to come - The Pharma Letter
Australia Anti-Venom Market Analysis Report 2025-2033 - GlobeNewswire
Corneal Ulcer Treatment Market Driven by Innovation from Dr. Reddy’s to Pfizer, Set for Significant Growth - FMIBlog
Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com
Pfizer’s Phase 3 Study on Elranatamab: A Potential Game-Changer in Multiple Myeloma Treatment - TipRanks
Pfizer Stock Is a Value Play Ahead of EarningsInvestors Can Short PFE Puts for Income - Yahoo Finance
Pfizer’s Promising Study on Disitamab Vedotin for Advanced Breast Cancer - TipRanks
Pfizer’s New Study on Elranatamab: A Potential Game-Changer in Multiple Myeloma Treatment? - TipRanks
Bristol-Myers Squibb and Pfizer’s Promising Study in Multiple Myeloma Treatment - TipRanks
0.79%
자본화:
|
볼륨(24시간):